Pharmacy Disclosure Log 2023

1. AML and CLL Response 7920
2. AML and CLL Response 8462
3. Antibiotic Administration Set Line Flushing Response 8129
4. Anti-Diabetic Products for the Formulary Response 7953
5. Asthma Treatment Response 8046
6. Asthma Response 8290
7. Asthma Response 8521
8. Biologic and Biosimilar Products Response 7883
9. Biologic and Biosimilar Products Response 8090
10. Biologic Medicines in Dermatology Response 8093
11. Biologic Medicines in Dermatology Response 7889
12. Biologic Medicines in Gastroenterology Response 8136
13. Biologic Medicines in Gastroenterology Response 8383
14. Biologic Medicines in Dermatology Response 8333
15. Biologic Drugs Response 8351
16. Biologic and Biosimilar Products Response 8328
17. Bladder Cancer Response 8486
18. Blood Cultures Response 8407
19. Blood Tests in Maternity Services Response 8202
20. Breast Cancer Response 8165
21. Breast Cancer Response 8404
22. Cancer Treatments Response 8334
23. Cancer Treatments Response 8334 - Attachment
24. Cancer Treatment Response 8383
25. Chitin Chitosan Response 8186
26. Colorectal Cancer Response 8487
27. Dabrafenib and Trametinib in cancer treatment Response 8031
28. Dermatology and Respiratory Medicine Response 8054
29. Dermatological Conditions Response 8055
30. Digital Test Results Access for Patient Response 8345
31. Durolane Response 8536
32. Early Access to Medicines Scheme (EAMS) Response 8051
33. Formularies and Committees Response 8120
34. Electronic Prescribing System Response 8417
35. Gastric Oesophageal cancer and Ovarian Cancer Response 8468
36. Gastroenterology Response 7930
37. HIV & PrEP Response 8183
38. Histology Response 8104
39. Histology Response Attachment 8104
40. Homecare Medicine Services Response 8262
41. Homecare Medicine Services Response 8262 - Attachment
42. Immunoglobulin Treatments Response 8460
43. Immunomodulatory Medications Response 8331
44. Immunoglobulin Treatments Response 8017
45. Incidence and Treatment of Urothelial and Colorectal Cancer Response 8218
46. Intraosseous Blood Samples Response 8098
47. Intra-Vitreal Injections or Implants Response 8343
48. Intra-Vitreal Treatments Response 8378
49. Juvenile Arthritis with Systemic Onset Response 8511
50. Local Formulary Response 7898
51. Lung Cancer Response 8389
52. Lung Cancer Response 8158
53. Lung Cancer Request 8158 - Attachment
54. Medications within Dermatology and Respiratory Medicine Response 8281
55. Migraine Response 8147
56. Multiple Myeloma Response 8184
57. Myelofibrosis Response 8465
58. Myelofibrosis Response 8194
59. Myelofibrosis Response 8194 - Attachment
60. NHS Healthcare Treatment Response 8131
61. NHS Drug Expiry Costs Response 8016
62. Nivolumab Response 8241
63. Nivolumab Response 8533
64. Non-Small Cell Lung Cancer Response 8217
65. Oesophageal and Gastric Cancer Response 8210
66. Non-Small Cell Lung Cancer Response 7952
67. Oesophageal and Gastric Cancer Response 7991
68. Ovarian Cancer Response 8106
69. Patients Receiving Treatment Response 8212
70. Pharmacy & Prescribing Function Response 8339
71. Pharmacy & Prescribing Function Response 8339 Attachment
72. Pharmacy Aseptic Services Response 8348
73. Pharmacy Aseptic Services Response 8415
74. Rare Diseases Response 8418
75. Rare Diseases Response 8418 -Attachment
76. Renal Cell Carcinoma Response 8161
77. Renal Cell Carcinoma Response 8161 Attachment
78. Renal Cell Carcinoma Response 8396
79. Renal Cell Carcinoma Response 8396 - Attachment
80. Renal Cell Carcinoma Response 7957
81. Renal Cell Carcinoma Response 7957 - Attachment
82. Ruxolitinib Response 8270
83. Self-Administration of Medication Response 8105
84. Spinal Muscular Atrophy Response 7886
85. Spinal Muscular Atrophy Response 7886 - Attachment
86. Targeted Medications within Dermatology Response 8509
87. Treatment of Dermatological Conditions Response 8296
88. Treatment of Inflammatory Diseases Response 8293
89. Treatment of Inflammatory Diseases Response 8293 - Attachment
90. Treatments Response 8455
91. Treatment of Breast Cancer Response 7965
92. Treatment for Myelofibrosis Response 7986
93. Treatment of Myelofibrosis Response 7986 - Attachment
94. Treatment of Melanoma Response 8032
95. Treatment of Urothelial and Colorectal Cancer Response 7998
96. Unlicensed Aseptically Prepared Medicines Response 8213
97. Unlicensed Aseptically Prepared Medicines Response 8213 - Attachment
98. Uterine Fibroids or Endometriosis Response 8315
99. Uterine Fibroids or Endometriosis Response 8315 - Attachment

• Share:
• Facebook
• Twitter
• LinkedIn